Entry Point Capital, LLC Neogenomics Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,428 shares of NEO stock, worth $68,456. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,428Holding current value
$68,456% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$304 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$218 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$136 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$104 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$102 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.94B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...